Mark S. Roth

1.8k total citations
18 papers, 1.4k citations indexed

About

Mark S. Roth is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology. According to data from OpenAlex, Mark S. Roth has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Genetics and 7 papers in Hematology. Recurrent topics in Mark S. Roth's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Mark S. Roth is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Mark S. Roth collaborates with scholars based in United States and Poland. Mark S. Roth's co-authors include Joseph H. Antin, C McGarigle, David Porter, James L.M. Ferrara, William R. Drobyski, Valeri H. Terry, Yvonne H. Datta, Stephen P. Ethier, Kenneth A. Foon and David Ginsburg and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Mark S. Roth

18 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Roth United States	13	636	569	458	310	299	18	1.4k
Rogers C. Griffith United States	17	294 0.5×	445 0.8×	245 0.5×	376 1.2×	390 1.3×	35	1.5k
HE Heslop United States	18	485 0.8×	460 0.8×	592 1.3×	169 0.5×	313 1.0×	32	1.4k
PC Nowell United States	16	352 0.6×	219 0.4×	327 0.7×	235 0.8×	339 1.1×	27	1.0k
P K Pattengale United States	22	265 0.4×	487 0.9×	502 1.1×	284 0.9×	572 1.9×	38	1.6k
Hitoshi Suzushima Japan	19	571 0.9×	369 0.6×	1.0k 2.2×	251 0.8×	561 1.9×	57	1.9k
Kazuhiro Nishida Japan	22	639 1.0×	370 0.7×	220 0.5×	458 1.5×	706 2.4×	87	1.6k
H Mizoguchi Japan	17	353 0.6×	506 0.9×	602 1.3×	89 0.3×	345 1.2×	54	1.4k
KJ Trainor Australia	14	257 0.4×	528 0.9×	360 0.8×	756 2.4×	338 1.1×	19	1.6k
Andries C. Bloem Netherlands	23	792 1.2×	628 1.1×	709 1.5×	140 0.5×	706 2.4×	57	1.9k
Charles L. Goolsby United States	23	336 0.5×	406 0.7×	437 1.0×	569 1.8×	442 1.5×	58	1.7k

Countries citing papers authored by Mark S. Roth

Since Specialization

Citations

This map shows the geographic impact of Mark S. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Roth more than expected).

Fields of papers citing papers by Mark S. Roth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Roth. The network helps show where Mark S. Roth may publish in the future.

Co-authorship network of co-authors of Mark S. Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Roth. A scholar is included among the top collaborators of Mark S. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Roth. Mark S. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Reddy, Nishitha, Francisco J. Hernandez‐Ilizaliturri, George Deeb, et al.. (2007). Immunomodulatory drugs stimulate natural killer‐cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti‐tumour activity of rituximab in vivo. British Journal of Haematology. 140(1). 36–45. 219 indexed citations

Porter, David, et al.. (1996). Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.. PubMed. 18(5). 975–80. 85 indexed citations

Porter, David, Mark S. Roth, C McGarigle, James L.M. Ferrara, & Joseph H. Antin. (1994). Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia. New England Journal of Medicine. 330(2). 100–106. 395 indexed citations

Datta, Yvonne H., et al.. (1994). Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.. Journal of Clinical Oncology. 12(3). 475–482. 374 indexed citations

Hessner, Martin J., Mark S. Roth, William R. Drobyski, & L.A. Baxter-Lowe. (1994). Development of a sensitive, highly controlled assay for molecular detection of the Philadelphia chromosome in patients with chronic myelogenous leukemia. Genetic Analysis Biomolecular Engineering. 11(4). 90–94. 11 indexed citations

Shah, Aarti R., et al.. (1992). A Clinicopathologic Study of Familial Chronic Lymphocytic Leukemia. American Journal of Clinical Pathology. 97(2). 184–188. 4 indexed citations

Roth, Mark S., George J. Weiner, Valeri H. Terry, et al.. (1990). Molecular characterization of anti-idiotype antibody-resistant variants of a murine B cell lymphoma.. The Journal of Immunology. 145(2). 768–777. 11 indexed citations

Roth, Mark S., Joseph H. Antin, Eve L. Bingham, & David Ginsburg. (1990). USE OF POLYMERASE CHAIN REACTION-DETECTED SEQUENCE POLYMORPHISMS TO DOCUMENT ENGRAFTMENT FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION. Transplantation. 49(4). 714–719. 44 indexed citations

Hanson, Curtis A., Elizabeth A. Holbrook, S. Sheldon, Bertram Schnitzer, & Mark S. Roth. (1990). Detection of Philadelphia chromosome-positive cells from glass slide smears using the polymerase chain reaction.. PubMed. 137(1). 1–6. 19 indexed citations

10.

Sieving, Paul A., Eve L. Bingham, Mark S. Roth, et al.. (1990). Linkage relationship of X-linked juvenile retinoschisis with Xp22.1-p22.3 probes.. PubMed. 47(4). 616–21. 32 indexed citations

11.

Roth, Mark S., Paul A. Bunn, & Kenneth A. Foon. (1988). Interferon therapy for lymphoproliferative disorders. Cancer treatment and research. 38. 231–252. 10 indexed citations

12.

Schnitzer, Bertram, et al.. (1988). Ki-1 lymphomas in children. Cancer. 61(6). 1213–1221. 67 indexed citations

13.

Roth, Mark S., et al.. (1988). Rearrangement of immunoglobulin and T-cell receptor genes in Hodgkin's disease.. PubMed. 131(2). 331–8. 49 indexed citations

14.

Roth, Mark S., et al.. (1987). Light chain disease associated with the hyperviscosity syndrome. Cancer. 60(9). 2267–2268. 13 indexed citations

15.

Foon, Kenneth A., Mark S. Roth, & Paul A. Bunn. (1987). Interferon therapy of non-Hodgkin's lymphoma. Cancer. 59(S3). 601–604. 24 indexed citations

16.

Roth, Mark S. & Kenneth A. Foon. (1986). Alpha interferon in the treatment of hematologic malignancies. The American Journal of Medicine. 81(5). 871–882. 64 indexed citations

17.

McDonnell, W. Michael, Mark S. Roth, & John N. Sheagren. (1986). Hemophilus influenzae type B cellulitis in adults. The American Journal of Medicine. 81(4). 709–712. 5 indexed citations

18.

Foon, Kenneth A., Mark S. Roth, & Paul A. Bunn. (1986). Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.. PubMed. 13(3 Suppl 2). 35–42. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact